Alkermes ALKS
NASDAQ ALKS
$48.58 -1.60 (-3.19%)
At close: Aug 20, 2026 · 2:04 PM UTC

Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026)

Alkermes (ALKS) posted quarterly Change in Acquisitions & Divestments of $20.1 million for Q2 2026, down 75.38% year-over-year from $81.6 million in Q2 2025, and down 52.86% quarter-over-quarter from $42.6 million in Q1 2026.

Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $20.1 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments fell 75.38% year-over-year to $20.1 million; the TTM figure through Jun 2026 stood at $565.1 million (up 54.23% YoY), while the FY2025 annual figure was $697.5 million, up 124.79% from the prior year.
  • Change in Acquisitions & Divestments retreated to $20.1 million in Q2 2026 per ALKS's latest filing, from $42.6 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $377.1 million in Q4 2025 and bottomed at $20.1 million in Q2 2026.
  • Historically, Change in Acquisitions & Divestments has averaged $94.9 million across 5 years, with a median of $82.0 million in 2024.
  • Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 341.06% — and 2026, when it slumped 75.38%.
  • Alkermes' Change in Acquisitions & Divestments stood at $90.6 million in 2022, then declined by 29.85% to $63.6 million in 2023, then soared by 34.48% to $85.5 million in 2024, then surged by 341.06% to $377.1 million in 2025, then slumped by 94.67% to $20.1 million in 2026.
  • Business Quant data shows ALKS's Change in Acquisitions & Divestments at $20.1 million in Q2 2026, $42.6 million in Q1 2026, and $377.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 20.09 Mn
Jun 30, 2026 20.09 Mn
Mar 31, 2026 42.61 Mn
Mar 31, 2026 42.61 Mn
Dec 31, 2025 377.11 Mn
Dec 31, 2025 377.11 Mn
Sep 30, 2025 125.31 Mn
Sep 30, 2025 125.31 Mn
Jun 30, 2025 81.59 Mn
Jun 30, 2025 81.59 Mn
Mar 31, 2025 113.49 Mn
Mar 31, 2025 113.49 Mn
Dec 31, 2024 85.50 Mn
Dec 31, 2024 85.50 Mn
Sep 30, 2024 85.84 Mn
Sep 30, 2024 85.84 Mn
Jun 30, 2024 56.46 Mn
Jun 30, 2024 56.46 Mn
Mar 31, 2024 82.49 Mn
Mar 31, 2024 82.49 Mn